INVO Fertility, Inc.
IVFNASDAQHealthcare● Active
$1.34
+$0.04(+2.69%)
Market Cap$1858614
P/E Ratio—
52W High$183.6
52W Low$1.265
INVO Fertility, Inc. (IVF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
IVF · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2026Report Date: May 6, 2026EPS Actual
-$2.75
Est. -$2.75 · +0.0%
Revenue
$0.00B
Est. $0.00B · +0.0%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 6, 2026
After Market Close
✓ 2-Quarter EPS Beat Streak
IVF reports quarterly as a NASDAQ-listed Medical - Devices company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q2 FY2026 | May 18, 2026 | -$1.25 | — | — | — | $0.00B | — |
| — Q2 FY2026 | May 6, 2026 | -$2.75 | -$2.75 | +0.0% | $0.00B | $0.00B | +0.0% |
| ▲ Q4 FY2025 | Nov 17, 2025 | -$11.52 | -$6.16 | +46.5% | $0.00B | $0.00B | -3.2% |
| ▼ Q3 FY2025 | Aug 14, 2025 | -$14.40 | -$63.60 | -341.7% | $0.00B | $0.00B | -1.1% |
| ▼ Q2 FY2025 | May 20, 2025 | -$14.40 | -$300.75 | -1988.5% | $0.00B | $0.00B | +1.9% |
| — Q4 FY2024 | Dec 31, 2024 | — | -$11.71 | — | $0.00B | — | — |
| ▲ Q4 FY2024 | Nov 19, 2024 | -$25.92 | -$5.04 | +80.6% | $0.00B | $0.00B | -64.5% |
| ▲ Q3 FY2024 | Aug 14, 2024 | -$40.32 | -$0.62 | +98.5% | $0.00B | $0.00B | -43.9% |
Q2 FY2026
May 18, 2026
EPS Actual
—
EPS Est.
-$1.25
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 6, 2026
EPS Actual
-$2.75
EPS Est.
-$2.75
EPS Surpr.
+0.0%
Revenue
$0.00B
Q4 FY2025
Nov 17, 2025Beat
EPS Actual
-$6.16
EPS Est.
-$11.52
EPS Surpr.
+46.5%
Revenue
$0.00B
Q3 FY2025
Aug 14, 2025Miss
EPS Actual
-$63.60
EPS Est.
-$14.40
EPS Surpr.
-341.7%
Revenue
$0.00B
Q2 FY2025
May 20, 2025Miss
EPS Actual
-$300.75
EPS Est.
-$14.40
EPS Surpr.
-1988.5%
Revenue
$0.00B
Q4 FY2024
Dec 31, 2024
EPS Actual
-$11.71
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q4 FY2024
Nov 19, 2024Beat
EPS Actual
-$5.04
EPS Est.
-$25.92
EPS Surpr.
+80.6%
Revenue
$0.00B
Q3 FY2024
Aug 14, 2024Beat
EPS Actual
-$0.62
EPS Est.
-$40.32
EPS Surpr.
+98.5%
Revenue
$0.00B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.00 | $0.00 | $0.00 | 0 |
| Q3 FY2028 | $0.00 | $0.00 | $0.00 | 0 |
| Q2 FY2028 | $0.00 | $0.00 | $0.00 | 0 |
| Q1 FY2028 | $0.00 | $0.00 | $0.00 | 0 |
| Q4 FY2027 | $0.00 | $0.00 | $0.00 | 0 |
| Q3 FY2027 | $0.00 | $0.00 | $0.00 | 0 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 6, 2026 | +0.0% | $1.89 | $1.81 | -4.23% |
| ▲ Q4 FY2025 | Nov 17, 2025 | +46.5% | $19.30 | $18.30 | -5.18% |
| ▼ Q3 FY2025 | Aug 14, 2025 | -341.7% | $68.80 | $70.00 | +1.74% |
| ▼ Q2 FY2025 | May 20, 2025 | -1988.5% | $260.40 | $261.60 | +0.46% |
| — Q4 FY2024 | Dec 31, 2024 | — | $1,130.40 | $1,166.40 | +3.18% |
| ▲ Q4 FY2024 | Nov 19, 2024 | +80.6% | $1,169.30 | $1,170.70 | +0.12% |
| ▲ Q3 FY2024 | Aug 14, 2024 | +98.5% | $1,347.85 | $1,287.35 | -4.49% |
| ▲ Q2 FY2024 | May 15, 2024 | +99.1% | $1,612.80 | $1,540.80 | -4.46% |
Q2 FY2026-4.23%
Report Date
May 6, 2026
EPS Beat/Miss
+0.0%
Price Before
$1.89
Price After
$1.81
Q4 FY2025-5.18%
Report Date
Nov 17, 2025
EPS Beat/Miss
+46.5%
Price Before
$19.30
Price After
$18.30
Q3 FY2025+1.74%
Report Date
Aug 14, 2025
EPS Beat/Miss
-341.7%
Price Before
$68.80
Price After
$70.00
Q2 FY2025+0.46%
Report Date
May 20, 2025
EPS Beat/Miss
-1988.5%
Price Before
$260.40
Price After
$261.60
Q4 FY2024+3.18%
Report Date
Dec 31, 2024
EPS Beat/Miss
—
Price Before
$1,130.40
Price After
$1,166.40
Q4 FY2024+0.12%
Report Date
Nov 19, 2024
EPS Beat/Miss
+80.6%
Price Before
$1,169.30
Price After
$1,170.70
Q3 FY2024-4.49%
Report Date
Aug 14, 2024
EPS Beat/Miss
+98.5%
Price Before
$1,347.85
Price After
$1,287.35
Q2 FY2024-4.46%
Report Date
May 15, 2024
EPS Beat/Miss
+99.1%
Price Before
$1,612.80
Price After
$1,540.80
Avg Beat Reaction-3.65%
Avg Miss Reaction+1.10%
Beat Rate5 / 8 quarters
Largest Move-5.18% (Q4 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: IVF ends December
INVO Fertility, Inc. (IVF) most recently reported earnings on May 6, 2026 for Q2 FY2026, posting EPS of $-2.75 (in line with the analyst consensus of $-2.75). IVF has beaten EPS estimates for 2 consecutive quarters. The next IVF earnings date is expected around September 1, 2026.
Each quarter, investors track IVF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. IVF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
IVF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
IVF earnings · 4 questionsINVO Fertility, Inc.'s next earnings report is expected around September 1, 2026. IVF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; IVF historically reports after market close (AMC).
IVF earnings datewhen is IVF earningsIVF next earnings datewhen does IVF report earningsIVF earnings calendar
▸ Source: FMP · INVO Fertility, Inc. SEC filings · US GAAP · INVO Fertility, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026